This November, we are pleased to be celebrating the Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation’s 50th anniversary, commemorating five decades of jumpstarting the careers of more than 2,200 young scientists through $80 million in grant and fellowship awards.
Following a record-breaking year in 2015 of $3.6 million in new grants and fellowships to 43 young scientists, the Foundation is set to award $3.5 million in 2016 to 43 additional researchers.
Awards from the Foundation come at a critical point in young scientists’ careers, when they are beginning to establish themselves in their respective fields. Grant and fellowship funds are often used to establish labs, conduct experiments and explore novel disease targets.
The unrestricted nature of the funding allows recipients to explore their true passions and establish their footing on a path toward careers in the research and development of new, innovative treatments to improve patient outcomes across a broad range of illnesses. Foundation alumni include deans of colleges, a Nobel Laureate, a former U.S. Food and Drug Administration (FDA) Commissioner, FDA directors, department chairs and professors at universities and heads of research at major corporations and biopharmaceutical companies.
To recognize alumni who received grants at the outset of their careers and have gone on to establish themselves as distinguished leaders in their field, each year the Foundation grants Awards in Excellence to past awardees who are living proof that the Foundation program works and makes a difference.
In addition to research grants, the Foundation operates a number of educational initiatives including a rotation program for regulatory science fellows, educational modules for future prescribers to promote safe and effective prescribing practices and conferences on topics such as medication adherence improvement and comparative effectiveness research.
As we celebrate this golden anniversary and take a moment to reflect upon the past grantees’ successes, we also look forward to continuing our commitment to and investment in young scientists driving improved health outcomes for patients worldwide.
Read more about the PhRMA Foundation: